1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow AD 101: new trials by email Literature Review of AD 101 trials Research Report on AD 101
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating the Pharmacokinetic Characteristics of AD-101 in Healthy Volunteers AD-101 45mg, Raloxifene 60mg - Osteoporosis | Phase 1 | Completed | Addpharma Inc. | 52 | 2018-12-14 | 2019-08-30 |
Osteoporosis (1)
Addpharma Inc. (1)
South Korea (1)